Company profile
Intellomx for Novel Molecular Discovery
Intellomx technology using artificial intelligence for novel molecular discovery
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUyMzYxODczOGFkaXF6a2N4
Published 26 May 2026 07:37
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2021 to 31 Dec 2021
1 Nov 2020 to 30 Apr 2021
Drug discovery is an expensive, time consuming, and unsustainable process requiring large teams, significant use of animal models, and extensive physical laboratory resources. The process is also prone to failure because many of the methods used are unrepresentative of the disease state or organism being targetted. Despite the significant investment of bi...
1 Nov 2013 to 31 Jan 2017
Bovine tuberculosis (M. bovis) remains a major disease of cattle in the United Kingdom. The diagnosis and management of infected herds represents a significant burden to the UK taxpayer as bovine tuberculosis is a notifiable disease. Current testing regimens are laborious and time consuming, with blood samples needing to be transported to centralised test...
